{"entities":{"Q9896":{"pageid":14057,"ns":120,"title":"Item:Q9896","lastrevid":205814,"modified":"2020-05-21T15:47:39Z","type":"item","id":"Q9896","labels":{"en":{"language":"en","value":"Hainsworth JD, et al. Target Oncol. (2016) cited as Ref 633 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9896$9C55C6B7-D16A-4DC8-AB88-6F2CA920DDBC","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9896$6F8AB53A-BBDB-47E3-8FCB-1F25D59AA683","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Hainsworth JD","type":"string"},"datatype":"string"},"type":"statement","id":"Q9896$C1F481F1-8488-4AAD-AEDE-F2DA024F6EB0","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.1007/s11523-016-0434-9","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9896$41B0F0B0-553A-4997-B57B-6C6112FB0062","rank":"normal"}],"P140":[{"mainsnak":{"snaktype":"value","property":"P140","datavalue":{"value":"27154357","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9896$C335CDCA-EC9A-4AE3-95C6-1DC300C44A10","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2016-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9896$B38FBB10-F828-41B3-9835-ADBB48EB1CF7","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Target Oncol.","type":"string"},"datatype":"string"},"type":"statement","id":"Q9896$56017BDF-1FAA-43C1-A177-80235E7150C3","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"11","type":"string"},"datatype":"string"},"type":"statement","id":"Q9896$21DF6E9F-7DE5-4E50-9276-8112F99A3BFC","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"A randomized open-label phase 2 study of the CXCR4 inhibitor LY2510924 in combination with sunitinib versus sunitinib alone in patients with metastatic renal cell carcinoma (RCC)","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9896$7FB2232F-9FC3-44D3-8489-332CBC3EAFE9","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"643-653","type":"string"},"datatype":"string"},"type":"statement","id":"Q9896$10101FFA-649A-4092-ABC2-DE3895BF31B8","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Hainsworth JD, et al. Target Oncol. (2016) cited as Ref 633 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Hainsworth_JD,_et_al._Target_Oncol._(2016)_cited_as_Ref_633_in_DOI:_10.1038/s41392-020-0110-5"}}}}}